Relay Therapeutics RLAY
NASDAQ RLAY
$18.49 +0.44 (+2.44%)
At close: Oct 1, 2026 · 4:00 PM EDT

Relay Therapeutics (RLAY) Liabilities and Shareholders Equity (2019 - 2026)

Updated

Relay Therapeutics (RLAY) recorded Liabilities and Shareholders Equity of $967.46 million in Q2 2026, up 32.7% from $728.84 million a year earlier and up 38.3% from the prior quarter.

Analysis

Relay Therapeutics (RLAY) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Relay Therapeutics reported Liabilities and Shareholders Equity of $621.33 million, down 28.7% from FY2024.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of -4.9% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $871.3 million in FY2024 (+3.2%), $843.98 million in FY2023 (-23.3%), $1.1 billion in FY2022 (+9.1%) and $1.01 billion in FY2021 (+26.1%).
  • The Q2 2026 figure is the highest quarterly Liabilities and Shareholders Equity since Q1 2023.
  • On a year-over-year basis, Liabilities and Shareholders Equity rose in three of the last eight quarters, with an average decline of 5.2%.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 74.0% in Q3 2022, against a decline of 28.7% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $699.61 million (Q1 2026), $621.33 million (Q4 2025) and $670 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Relay Therapeutics 3.94 Bn 3.94 Bn - 967.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 967.46 Mn
Mar 31, 2026 699.61 Mn
Dec 31, 2025 621.33 Mn
Sep 30, 2025 670.00 Mn
Jun 30, 2025 728.84 Mn
Mar 31, 2025 799.36 Mn
Dec 31, 2024 871.30 Mn
Sep 30, 2024 930.12 Mn
Jun 30, 2024 772.55 Mn
Mar 31, 2024 841.44 Mn
Dec 31, 2023 843.98 Mn
Sep 30, 2023 906.96 Mn
Jun 30, 2023 962.02 Mn
Mar 31, 2023 1.04 Bn
Dec 31, 2022 1.10 Bn
Sep 30, 2022 1.17 Bn
Jun 30, 2022 889.42 Mn
Mar 31, 2022 949.88 Mn
Dec 31, 2021 1.01 Bn
Sep 30, 2021 671.62 Mn
API Access

Relay Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RLAY&period=max&api_key=YOUR_API_KEY